De Robertis, M.; Greco, M.R.; Cardone, R.A.; Mazza, T.; Marzano, F.; Mehterov, N.; Kazakova, M.; Belev, N.; Tullo, A.; Pesole, G.;
et al. Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer. Cells 2022, 11, 3568.
https://doi.org/10.3390/cells11223568
AMA Style
De Robertis M, Greco MR, Cardone RA, Mazza T, Marzano F, Mehterov N, Kazakova M, Belev N, Tullo A, Pesole G,
et al. Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer. Cells. 2022; 11(22):3568.
https://doi.org/10.3390/cells11223568
Chicago/Turabian Style
De Robertis, Mariangela, Maria Raffaella Greco, Rosa Angela Cardone, Tommaso Mazza, Flaviana Marzano, Nikolay Mehterov, Maria Kazakova, Nikolay Belev, Apollonia Tullo, Graziano Pesole,
and et al. 2022. "Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer" Cells 11, no. 22: 3568.
https://doi.org/10.3390/cells11223568
APA Style
De Robertis, M., Greco, M. R., Cardone, R. A., Mazza, T., Marzano, F., Mehterov, N., Kazakova, M., Belev, N., Tullo, A., Pesole, G., Sarafian, V., & Signori, E.
(2022). Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer. Cells, 11(22), 3568.
https://doi.org/10.3390/cells11223568